Overview

Update
Status
Acquired by on April 22, 2008
IPO / Stock
Went Public on May 23, 2007 / NASDAQ:SIRT
Headquarters:
Cambridge, MA
Description:
Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.
Founders:
, , ,
Categories:
Pharmaceutical, Health Care, Biotechnology
Website:
http://www.sirtrispharma.com

Funding Rounds (4) - $82M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2006$37M / Series C2
Mar, 2005$27M / Series B8
Dec, 2004$13M / Series A5
Aug, 2004$5M / Seed0

Current Team (2)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Office

    200 Technology Square

    Suite 300

    Cambridge, MA 02139

    USA

Past Team (10)

Update

Images (2)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos